Securities litigation arising from the purchase or sale of digital products such as cryptocurrencies, nonfungible tokens (NFTs) and security tokens has proliferated in recent years. A gating question in these cases is whether...more
On January 12, 2018, the United States Supreme Court granted certiorari in Animal Science Products v. Hebei Welcome Pharmaceutical Co. (In re Vitamin C Antitrust Litigation), No. 16-1220. The issue before the Supreme Court is...more
1/26/2018
/ Animal Science Products Inc v Hebei Welcome Pharmaceutical Co Ltd ,
Antitrust Litigation ,
Appeals ,
Certiorari ,
China ,
Class Action ,
Comity ,
Corporate Counsel ,
Foreign Sovereign Immunities Act of 1976 (FSIA) ,
Foreign Sovereigns ,
International Litigation ,
Judicial Deference ,
Judicial Review ,
MOFCOM ,
Motion to Dismiss ,
Price-Fixing ,
SCOTUS ,
Sherman Act ,
The Clayton Act ,
Trump Administration ,
Vacated